Kuria Therapeutics
UEI: F7M7TD9GDA55
Overview
Awardee Type
Parent
Company Description
Kuria Therapeutics is developing a platform of novel Nrf2 activators to treat blinding diseases
Name
Kuria Therapeutics
Website
Headquarters
Little Rock, AR
United States
United States
Most Recent Award
Sept. 30, 2025
Calculating
Federal grant recipient
KURIA THERAPEUTICS, INC.
(UEI F7M7TD9GDA55)
is headquartered in Little Rock AR.
The corporation
was founded in February 2022 and
federally registered in
December 2023.
Federal Award Analysis
Kuria Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
KURIA THERAPEUTICS, INC.
UEI
F7M7TD9GDA55
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Feb. 14, 2022
Initial Registration
Dec. 6, 2023
Last Registration
Nov. 6, 2025
Registration Activation
Nov. 5, 2025
Registration Expiration
Nov. 3, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Reported NAICS
None Reported
Accepts Credit Cards
No